Literature DB >> 7698241

Transforming growth factors beta stimulate both thrombospondin-1 and CISP/thrombospondin-2 synthesis by bovine adrenocortical cells.

A Negoescu1, B Lafeuillade, S Pellerin, E M Chambaz, J J Feige.   

Abstract

We recently observed that adrenocortical cells secrete, under ACTH treatment, a large trimeric glycoprotein (CISP) presenting amino acid sequence similarity with thrombospondin-2. We also observed that the same cells synthesize and secrete thrombospondin-1 whereas under smaller amounts. The aim of this study was to investigate the regulation of these two secreted proteins by members of the TGF beta family of regulatory peptides. We developed an appropriate immunoprecipitation technique that allowed us to quantitate synthesis of thrombospondin-1 and CISP/thrombospondin-2 in a single assay. Using this assay, we observed that thrombospondin-1 and CISP/thrombospondin-2 syntheses were respectively stimulated threefold and twofold by a 24-h treatment with 2 ng/ml TGF beta 1. These inductions were dose-dependent (half-maximal effect: 0.2 ng/ml) and time-dependent (detectable after 5 h and plateauing between 15 and 25 h of treatment). They were not observed when transcription was blocked by RNA polymerase inhibitors such as 5,6-dichlorobenzimidazole riboside or actinomycin D. Among members of the TGF beta family, TGF beta 1 and TGF beta 2 and to a lesser extent activin could stimulate thrombospondin-1 and CISP/thrombospondin-2 synthesis, whereas inhibin and Müllerian inhibiting substance were inactive. Taken together, these data represent the first study on the regulation of both thrombospondin-1 and CISP/thrombospondin-2 by TGF betas. They further support the concept that TGF beta is a local regulator of adrenocortical functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698241     DOI: 10.1006/excr.1995.1103

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis.

Authors:  Rainer Kunstfeld; Thomas Hawighorst; Michael Streit; Young-Kwon Hong; Lynh Nguyen; Lawrence F Brown; Michael Detmar
Journal:  J Dermatol Sci       Date:  2014-01-18       Impact factor: 4.563

2.  Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

Authors:  Lisa M Rice; Cristina M Padilla; Sarah R McLaughlin; Allison Mathes; Jessica Ziemek; Salma Goummih; Sashidhar Nakerakanti; Michael York; Giuseppina Farina; Michael L Whitfield; Robert F Spiera; Romy B Christmann; Jessica K Gordon; Janice Weinberg; Robert W Simms; Robert Lafyatis
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

3.  SnoN: bridging neurobiology and cancer biology.

Authors:  I Pot; Y Ikeuchi; A Bonni; S Bonni
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

Review 4.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

5.  A SnoN-Ccd1 pathway promotes axonal morphogenesis in the mammalian brain.

Authors:  Yoshiho Ikeuchi; Judith Stegmüller; Stuart Netherton; Mai Anh Huynh; Masayuki Masu; David Frank; Shirin Bonni; Azad Bonni
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

6.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.